Research and optimization of the treatment of advanced gastric cancer with Chinese and Western medicine based on TCM tumor registration platform

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients with gastric cancer diagnosed pathologically;
•2. Patients with TNM stage ?;
•3. Patients with age = 18 years old, regardless of gender;
•4. Patients with Karnofsky score = 60;
•5. Patients who have been or will receive systematic Chinese medicine treatment (oral treatment of syndrome differentiation and treatment Decoction at the TCM oncologist's office);
•6. Patients who voluntarily accept the study and sign the informed consent form can cooperate with the follow-up once every 2 months, about 6 times, and cooperate to improve the current treatment measures and relevant information.

•1. Patients with two or more primary malignant tumors;
•2. Patients with serious non neoplastic diseases and dysfunction, active cerebrovascular diseases, uncontrolled infection and metabolic diseases, neuropsychiatric diseases, cognitive dysfunction and other important organs such as heart, lung, liver, kidney, etc;
•3. Patients can not or refuse to take oral medicine;
•4. The patients whose expected survival time is less than 3 months;
•5. Other situations that the researcher thinks are not suitable to participate in this clinical study.

发起方

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine